BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21083489)

  • 1. Effect of storage conditions on the weight and appearance of dried blood spot samples on various cellulose-based substrates.
    Denniff P; Spooner N
    Bioanalysis; 2010 Nov; 2(11):1817-22. PubMed ID: 21083489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of hematocrit on assay bias when using DBS samples for the quantitative bioanalysis of drugs.
    Denniff P; Spooner N
    Bioanalysis; 2010 Aug; 2(8):1385-95. PubMed ID: 21083339
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of dried blood spot sampling and storage for increased stability of photosensitive compounds.
    Bowen CL; Hemberger MD; Kehler JR; Evans CA
    Bioanalysis; 2010 Nov; 2(11):1823-8. PubMed ID: 21083490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid analysis of dried blood spot samples with sub-2-µm LC-MS/MS.
    Mather J; Rainville PD; Spooner N; Evans CA; Smith NW; Plumb RS
    Bioanalysis; 2011 Feb; 3(4):411-20. PubMed ID: 21338261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pre-cut dried blood spot (PCDBS): an alternative to dried blood spot (DBS) technique to overcome hematocrit impact.
    Youhnovski N; Bergeron A; Furtado M; Garofolo F
    Rapid Commun Mass Spectrom; 2011 Oct; 25(19):2951-8. PubMed ID: 21913274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of DBS sample collection to determine circulating drug concentrations in clinical trials: practicalities and considerations.
    Spooner N; Ramakrishnan Y; Barfield M; Dewit O; Miller S
    Bioanalysis; 2010 Aug; 2(8):1515-22. PubMed ID: 21083351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Utilization of dried blood spots within drug discovery: modification of a standard DiLab(®) AccuSampler(®) to facilitate automatic dried blood spot sampling.
    Clark GT; Giddens G; Burrows L; Strand C
    Lab Anim; 2011 Apr; 45(2):124-6. PubMed ID: 21355022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of individual quantitative methods for determination of cytochrome P450 probe substrates in human dried blood spots with HPLC-MS/MS.
    Lad R
    Bioanalysis; 2010 Nov; 2(11):1849-61. PubMed ID: 21083493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dried blood spot sampling for quantitative bioanalysis: time for a revolution?
    Spooner N
    Bioanalysis; 2010 Nov; 2(11):1781. PubMed ID: 21083481
    [No Abstract]   [Full Text] [Related]  

  • 10. A powerful couple in the future of clinical biochemistry: in situ analysis of dried blood spots by ambient mass spectrometry.
    Corso G; D'Apolito O; Gelzo M; Paglia G; Dello Russo A
    Bioanalysis; 2010 Nov; 2(11):1883-91. PubMed ID: 21083496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of specimen storage conditions on newborn dried blood spots used to assess Toxoplasma gondii immunoglobulin M (IgM).
    Mei JV; Li L; Rasmussen SA; Collier S; Frias JL; Honein MA; Shaw GM; Lorey F; Meyer R; Chaing S; Canfield MA; Jones J; Hannon WH
    Clin Chim Acta; 2011 Feb; 412(5-6):455-9. PubMed ID: 21114968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of the DBS methodology to a toxicokinetic study in rats and transferability of analysis between bioanalytical laboratories.
    Turpin PE; Burnett JE; Goodwin L; Foster A; Barfield M
    Bioanalysis; 2010 Aug; 2(8):1489-99. PubMed ID: 21083349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study to assess the effect of age of control human and animal blood on its suitability for use in quantitative bioanalytical DBS methods.
    Abu-Rabie P; Spooner N
    Bioanalysis; 2010 Aug; 2(8):1373-84. PubMed ID: 21083338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increasing efficiency for dried blood spot analysis: prospects for automation and simplified sample analysis.
    Wong P; Pham R; Bruenner BA; James CA
    Bioanalysis; 2010 Nov; 2(11):1787-9. PubMed ID: 21083483
    [No Abstract]   [Full Text] [Related]  

  • 15. A glowing future for dried blood spot sampling.
    Spooner N
    Bioanalysis; 2010 Aug; 2(8):1343-4. PubMed ID: 21083330
    [No Abstract]   [Full Text] [Related]  

  • 16. C-peptide in dried blood spots.
    Johansson J; Becker C; Persson NG; Fex M; Törn C
    Scand J Clin Lab Invest; 2010 Oct; 70(6):404-9. PubMed ID: 20602576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GlaxoSmithKline's experience of incurred sample reanalysis for dried blood spot samples.
    Barfield M; Ahmad S; Busz M
    Bioanalysis; 2011 May; 3(9):1025-30. PubMed ID: 21545350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of DBS technology for the detection of therapeutic antibodies.
    Prince PJ; Matsuda KC; Retter M; Scott G
    Bioanalysis; 2010 Aug; 2(8):1449-60. PubMed ID: 21083345
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exploring the feasibility of using the DBS technique for metabolite radioprofiling.
    Wang L; Zeng Z; Emmons G
    Bioanalysis; 2010 Aug; 2(8):1365-71. PubMed ID: 21083337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of ambient humidity on the rate at which blood spots dry and the size of the spot produced.
    Denniff P; Woodford L; Spooner N
    Bioanalysis; 2013 Aug; 5(15):1863-71. PubMed ID: 23905860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.